SME Times is powered by   
Search News
Just in:   • Tradeindia's 3 day- 'COVID-19 Essentials Expo India' to kick off on Aug 5  • Equity indices fall, RIL bucks trend to hit new high  • PC shipments worldwide grow 2.8% in Q2 as Lenovo, HP lead  • South Central Railway carries Andhra chillies to Bangladesh  • Mukesh Ambani world's 7th richest, overtakes Warren Buffet 
Last updated: 01 May, 2020  

Piyush.9.thmb.jpg India open to mutually benefitting collaborations: Goyal

Piyush.9.jpg.jpg
   Top Stories
» Tradeindia's 3 day- 'COVID-19 Essentials Expo India' to kick off on Aug 5
» Industrial output picks up in May
» 'RBI should ensure that banks lend to NBFCs'
» Forex reserves rise by $6 bn to $513 bn
» UP govt approves new start-up policy
SME Times News Bureau | 01 May, 2020

Minister of Commerce and Industry Piyush Goyal said on Friday that India is open to mutually benefitting collaborations with interested countries as far as the reciprocity in the deal is maintained.

Interacting with foreign missions in New Delhi, through Video Conference, he welcomed the interested countries who are planning to do business with India.

The Minister said that India gives the most importance to ‘the fair dealing and the reciprocity’ while signing any multilateral agreements. This was the reason because of which India didn’t participate in Regional Economic Comprehensive Partnership (RECP).

He advised that this is the best time to connect digitally for the planning of a road map for bilateral (or multilateral) agreements.

The Minister appealed to other countries for the collaborative efforts against the outspread of Coronavirus pandemic.

He said that India is ensuring the safety and well-being of the foreign nationals currently in India. He thanked them for participating in 9-minute light off, as asked by the PM on April 5.

Goyal said that the recent surveys and studies have proved that ‘the tough and appropriate role played by the PM of India during the crisis’ is the best stimulus against the crisis and it has been appreciated in the country as well as all around the world.

Mentioning about many world leaders including President Trump congratulating India for exporting medicines, Shri Goyal said that Indian Pharmaceuticals Industry is playing important role in producing and delivering medicines not only to India but also for the rest of the world.

Expressing confidence that India will play a leadership role in the Post- COVID world, he said that India is ensuring that no country will remain deprived of the essential medicines, especially underdeveloped countries. He assured them that if any assistance in the form of medicine is required from India, we will try to fulfill it.

But in the long term, we have to make a quick roadmap for the sustainable trade of the pharmacy sector. According to PM, as a global citizen, it is our responsibility to serve the one in need.

The Minister said that the role of PradhanMantriAyushman Bharat Scheme is going to be crucial during the pandemic.

He underlined the effectiveness of the immediate nationwide lockdown with a special reference to the high reduction in the rate of doubling the cases.

Goyal said that during this crisis, Government is forming long term strategies for the revival of the country’s economy out of the crisis. He said that this is a time to identify the true partner for our own countries to find collaborations in the future.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 11 Jul, 2020
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
» Pain points for MSMEs(3)
» UP govt to change lives of migrants: MSME Principal Secy(2)
» Starting an import export business: Basic guide for beginners(1)
» China's forex reserves reach USD 2.85 trillion(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter